Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2906-2914

  Hoogsteen, Ilse J ^a   Lok, Jasper ^a   Marres, Henri A M ^a   Takes, Robert P ^a   Rijken, Paul F J W ^a   van der Kogel, Albert J ^a   Kaanders, Johannes H A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Carbonic anhydrase IX; Larynx carcinoma; Pimonidazole; Tumour hypoxia; Tumour microenvironment

Indexed keywords

CARBONATE DEHYDRATASE IX; PIMONIDAZOLE;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DRUG BINDING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROENVIRONMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NITROIMIDAZOLES; RADIATION-SENSITIZING AGENTS;

EID: 70350097618     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.07.012     Document Type: Article

References (33)

1. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49 23 (1989) 6449-6465
2. Laconi E. The evolving concept of tumour microenvironments. Bioessays 29 8 (2007) 738-744
3. Vaupel P., and Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26 2 (2007) 225-239
4. Kaanders J.H.A.M., Wijffels K.I.E.M., Marres H.A.M., et al. Pimonidazole binding and tumour vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 23 (2002) 7066-7074
5. Schrijvers M.L., van der Laan B.F.A.M., de Bock G.H., et al. Overexpression of intrinsic hypoxia markers HIF1α and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 72 1 (2008) 161-169
6. Bache M., Kappler M., Said H.M., Staab A., and Vordermark D. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies. Curr Med Chem 15 4 (2008) 322-338
7. Raleigh J.A., Calkins-Adams D.P., Rinker L.H., et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58 17 (1998) 3765-3768
8. Arteel G.E., Thurman R.G., and Raleigh J.A. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 253 3 (1998) 743-750
9. Wijffels K.I.E.M., Marres H.A.M., Peters J.P.W., Rijken P.F.J.W., van der Kogel A.J., and Kaanders J.H.A.M. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas. Oral Oncol 44 4 (2008) 335-344
10. Hoogsteen I.J., Marres H.A.M., Bussink J., et al. Tumour microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck 29 6 (2007) 591-604
11. Supuran C.T. Carbonic anhydrases - an overview. Curr Pharm Des 14 7 (2008) 603-614
12. Swietach P., Vaughan-Jones R.D., and Harris A.L. Regulation of tumour pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26 2 (2007) 299-310
13. Schlingemann R.O., Dingjan G.M., Emeis J.J., et al. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 52 1 (1985) 71-76
14. Rijken P.F.J.W., Bernsen H.J.J.A., Peters J.P.W., et al. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys 48 2 (2000) 571-582
15. Ljungkvist A.S.E., Bussink J., Kaanders J.H.A.M., and van der Kogel A.J. Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat Res 167 2 (2007) 127-145
16. van Laarhoven H.W.M., Kaanders J.H.A.M., Lok J., et al. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer. Int J Radiat Oncol Biol Phys 64 2 (2006) 473-482
17. 2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study. Radiother Oncol 80 2 (2006) 123-131
18. Eriksen J.G., Overgaard J., and on behalf of the Danish Head and Neck Cancer Study Group (DAHANCA). Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. Radiother Oncol 83 3 (2007) 383-388
19. Tomasino R.M., Daniele E., Bazan V., et al. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Cancer Res 55 24 (1995) 6103-6108
20. Johansen L.V., Grau C., and Overgaard J. Laryngeal carcinoma. Multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy. Acta Oncol 42 7 (2003) 771-778
21. Yilmaz T., Hosal A.S., Gedikoglu G., and Kaya S. Prognostic significance of histopathological parameters in cancer of the larynx. Eur Arch Otorhinolaryngol 256 3 (1999) 139-144
22. Sahai A., Mei C., Zavosh A., and Tannen R.L. Chronic hypoxia induces LLC-PK1 cell proliferation and dedifferentiation by the activation of protein kinase C. Am J Physiol 272 6 Pt 2 (1997) F809-F815
23. Chou S.C., Azuma Y., Varia M.A., and Raleigh J.A. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinoma. Br J Cancer 90 3 (2004) 728-735
24. Azuma Y., Chou S.C., Lininger R.A., et al. Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin. Clin Cancer Res 9 13 (2003) 4944-4952
25. Wykoff C.C., Nigel J.P., Beasley N., et al. Hypoxia-inducible expression of tumour associated carbonic anhydrases. Cancer Res 60 24 (2000) 7075-7083
26. Jankovic B., Aquino-Parsons C., Raleigh J.A., et al. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B Clin Cytom 70 2 (2006) 45-55
27. Hoogsteen I.J., Marres H.A.M., Wijffels K.I.E.M., et al. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinomas. Clin Cancer Res 11 1 (2005) 97-106
28. Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B., and Gillies R.J. Acid-mediated tumour invasion: a multidisciplinary study. Cancer Res 66 10 (2006) 5216-5223
29. Ihnatko R., Kubes M., Takacova M., et al. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia. Int J Oncol 29 4 (2006) 1025-1033
30. Svastová E., Hulíková A., Rafajova M., et al. Hypoxia activates the capacity of tumour-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577 3 (2004) 439-445
31. Jonathan R.A., Wijffels K.I.E.M., Peeters W., et al. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 79 3 (2006) 288-297
32. Koukourakis M.I., Giatromanolaki A., Sivridis E., and Fezoulidis I. Cancer vascularization: Implications in radiotherapy?. Int J Radiat Oncol Biol Phys 48 2 (2000) 545-553
33. Kaanders J.H.A.M., Bussink J., and van der Kogel A.J. ARCON: a novel biology-based approach in radiotherapy. Lancet Oncol 3 12 (2002) 728-737